BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6817690)

  • 1. [Prevention of infectious complications in digestive surgery by the preoperative administration of cefoxitin. Multicenter study of 582 patients].
    Liégeois A; Brieu MA; Gervais MC; Loygue J
    Ann Chir; 1982 Oct; 36(7 Pt 2):545-53. PubMed ID: 6817690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylactic antibiotherapy with cefoxitin in abdominal surgery: results of an international multicenter study].
    Peltier AP
    Ann Chir; 1982 Oct; 36(7 Pt 2):557-61. PubMed ID: 6817692
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind, controlled comparison of piperacillin and cefoxitin in the prevention of postoperative infection in patients undergoing cesarean section.
    Benigno BB; Ford LC; Lawrence WD; Ledger WJ; Ling FW; McNeeley SG
    Surg Gynecol Obstet; 1986 Jan; 162(1):1-7. PubMed ID: 3079625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroperative cefoxitin. A double-blind prospective study in the prevention of wound infections.
    Utley RJ; Macbeth WA
    J R Coll Surg Edinb; 1984 May; 29(3):143-6. PubMed ID: 6379170
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of perioperative cefoxitin in the prevention of infectious complications of surgery in cancer of the upper respiratory-digestive tracts].
    Lacut JY; Renaud-Salis JL; Lakdja F; Dupon M
    Pathol Biol (Paris); 1985 May; 33(5):320-4. PubMed ID: 3897960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of sodium cefoxitin in the prevention of infections in patients subjected to general surgery].
    Giron GP; Pizzirani E; Nanni-Costa GP; Fiandri MT; Coli A; Simone M; Polese P; Verlato R; Vidali M
    Minerva Chir; 1988 Nov; 43(22):1959-62. PubMed ID: 3247033
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective double-blind comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing intra-abdominal operations.
    Baker RJ; Donahue PE; Finegold SM; Johnson WC; Middleton JR; Monafo WW; Wilson SE
    Surg Gynecol Obstet; 1985 Nov; 161(5):409-15. PubMed ID: 3901357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan vs. cefoxitin in short-term antibacterial prophylaxis in urological surgery.
    Rizzo M; Dami A; Mazzoccone A; Periti P
    Chemioterapia; 1987 Jun; 6(2 Suppl):609-11. PubMed ID: 3334646
    [No Abstract]   [Full Text] [Related]  

  • 9. Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy.
    Hemsell DL; Cunningham FG; Kappus S; Nobles B
    Obstet Gynecol; 1980 Nov; 56(5):629-34. PubMed ID: 7432735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery.
    Paladino JA; Rainstein MA; Serrianne DJ; Przylucki JE; Welage LS; Collura ML; Schentag JJ
    Pharmacotherapy; 1994; 14(6):734-9. PubMed ID: 7885978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cefotetan and cefoxitin as prophylaxis in high risk biliary surgery.
    Basoli A; Schietroma M; Fiocca F; Stabile G; Vigliardi G; Speranza V
    J Chemother; 1989 Jul; 1(4 Suppl):984-5. PubMed ID: 16312734
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefoxitin sodium: double-blind vaginal hysterectomy prophylaxis in premenopausal patients.
    Mickal A; Curole D; Lewis C
    Obstet Gynecol; 1980 Aug; 56(2):222-5. PubMed ID: 7393512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with cefoxitin in surgical sections of intensive care wards].
    Mingolla F; Feliciotti F
    Chir Ital; 1982 Jun; 34(3):404-16. PubMed ID: 6765343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short-term antimicrobial chemoprophylaxis in surgery at high risk for infectious complications: ceftriaxone versus cefoxitin ].
    Tristaino B; Talpacci A; Fabbri C; Giordano G; Raffi S
    Minerva Chir; 1988 Feb; 43(3):157-62. PubMed ID: 3374813
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of a double-blind, placebo-controlled clinical trial program of single-dose ceftizoxime versus multiple-dose cefoxitin as prophylaxis for patients undergoing vaginal and abdominal hysterectomy.
    McGregor JA; Phillips LE; Roy S; Dunne JT; Warwaruk AS; Johnston DW; Yuzpe AA; Hemsell DL
    J Am Coll Surg; 1994 Feb; 178(2):123-31. PubMed ID: 8173721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunonutrition in gastrointestinal surgery.
    Cerantola Y; Hübner M; Grass F; Demartines N; Schäfer M
    Br J Surg; 2011 Jan; 98(1):37-48. PubMed ID: 20931620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled trial and cost/efficacy evaluation of the prevention of infectious complications in surgery of cancers of the upper aerodigestive tract with peri-operative cefoxitin].
    Renaud-Salis JL; Lacut JY; Lakdja F; Dupon M; Faucher A
    Ann Otolaryngol Chir Cervicofac; 1985; 102(3):179-82. PubMed ID: 3925863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single-dose cefotetan and multidose cefoxitin as intravenous prophylaxis in elective, open biliary tract surgery: a multicentre, double-blind, randomized study.
    Lapointe RW; Roy AF; Turgeon PL; Lewis RT; Dagenais MH; Joly JR; Scudamore CH; Roy PD; Conly JM; Syrotuik J
    Can J Surg; 1994 Aug; 37(4):313-8. PubMed ID: 8055389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective comparative study of cefotetan versus cefoxitin against infection in elective colorectal surgery.
    Basoli A; Schietroma M; Fiocca F; Vigliardi G; Speranza V
    J Chemother; 1989 Jul; 1(4 Suppl):999-1001. PubMed ID: 16312742
    [No Abstract]   [Full Text] [Related]  

  • 20. Operative site bacteriology as an indicator of postoperative infectious complications in elective colorectal surgery.
    Grant SW; Hopkins J; Wilson SE
    Am Surg; 1995 Oct; 61(10):856-61. PubMed ID: 7668457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.